Receptos, Inc.

Located strategically in US innovation hubs, meanwhile stationing most of their development and regulatory personnel in central cities in China, dual-headquartered China-US biotechs have been riding h

Located strategically in hubs of innovation in the US, meanwhile stationing most of their development and regulatory personnel in central cities in China, dual-headquartered China-US biotechs have bee

ImmPACT Bio USA emerged from the FutuRx incubator in Israel in 2017 to develop chimeric antigen receptor T-cell (CAR-T) therapies that could be effective against solid tumors. Now, with $111m in seri

Two investment firms that focus on life science companies at their earliest stages said on 2 April that they have raised a total of $2.56bn across three venture capital funds – Flagship Pioneering wit